Molecular and clinical factors affecting myocardial iron retention in transfusional haemosiderosis

Myocardial haemosiderosis (MH) complicates Transfusion Dependent Thalassaemias (TDT), increasing mortality from cardiomyopathy. Plasma non-transferrin-bound iron (NTBI) and its redox-active component, labile plasma iron (LPI), are potential causes of MH. In 73 TDT patients, those with MH had signifi...

Full description

Bibliographic Details
Main Author: Garbowski, M. W.
Published: University College London (University of London) 2017
Subjects:
Online Access:https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.763167
id ndltd-bl.uk-oai-ethos.bl.uk-763167
record_format oai_dc
spelling ndltd-bl.uk-oai-ethos.bl.uk-7631672019-03-05T15:54:00ZMolecular and clinical factors affecting myocardial iron retention in transfusional haemosiderosisGarbowski, M. W.2017Myocardial haemosiderosis (MH) complicates Transfusion Dependent Thalassaemias (TDT), increasing mortality from cardiomyopathy. Plasma non-transferrin-bound iron (NTBI) and its redox-active component, labile plasma iron (LPI), are potential causes of MH. In 73 TDT patients, those with MH had significantly lower soluble transferrin receptors (sTfR) than those without. By contrast, transfusion duration, iron-loading rate (ILR), NTBI and transferrin saturation (TfSat) were similar in both groups. MH occurred only when ILR exceeded the erythroid transferrin uptake rate (ETUR) derived from sTfR, by >0.21mg/kg/d. LPI was >3-fold higher above this ETUR threshold, while NTBI and TfSat showed no difference, implicating the LPI fraction of NTBI in MH. We hypothesized that high ETUR decreases MH through increased generation of apotransferrin by the erythron. We used a cardiomyocyte (HL-1) cell line to explore the effects of NTBI speciation (iron:citrate ratio) and apotransferrin on iron uptake. Uptake was most efficient when citrate exceeded iron >100-fold, as was intracellular ROS formation and extracellular iron detectability using the LPI assay. Apotransferrin, when in excess, inhibited iron uptake, decreased intracellular ROS and decreased NTBI species detectable by LPI assay. However, at very high NTBI concentrations (≥10µM), when the iron content of ferric citrate (FC) exceeded the binding capacity of ApoTf, iron uptake was increased above that seen without transferrin present. Under these conditions ferric monocitrate species exist that are both LPI-detectable and enter myocardium. We propose that in TDT, transient generation of ApoTf under conditions of high residual erythropoiesis decreases MH by binding LPI-detectable species of NTBI. Qualitative differences in NTBI are therefore crucial to predict MH in TDT. Attempting to demonstrate relevant NTBI speciation differences we compared two methods: NTA-NTBI and a novel bead-NTBI. This approach, however, highlighted important methodological drawbacks rather than positive species identification; therefore, more work is needed in NTBI detection to elucidate the speciation further.616.1University College London (University of London)https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.763167http://discovery.ucl.ac.uk/1553159/Electronic Thesis or Dissertation
collection NDLTD
sources NDLTD
topic 616.1
spellingShingle 616.1
Garbowski, M. W.
Molecular and clinical factors affecting myocardial iron retention in transfusional haemosiderosis
description Myocardial haemosiderosis (MH) complicates Transfusion Dependent Thalassaemias (TDT), increasing mortality from cardiomyopathy. Plasma non-transferrin-bound iron (NTBI) and its redox-active component, labile plasma iron (LPI), are potential causes of MH. In 73 TDT patients, those with MH had significantly lower soluble transferrin receptors (sTfR) than those without. By contrast, transfusion duration, iron-loading rate (ILR), NTBI and transferrin saturation (TfSat) were similar in both groups. MH occurred only when ILR exceeded the erythroid transferrin uptake rate (ETUR) derived from sTfR, by >0.21mg/kg/d. LPI was >3-fold higher above this ETUR threshold, while NTBI and TfSat showed no difference, implicating the LPI fraction of NTBI in MH. We hypothesized that high ETUR decreases MH through increased generation of apotransferrin by the erythron. We used a cardiomyocyte (HL-1) cell line to explore the effects of NTBI speciation (iron:citrate ratio) and apotransferrin on iron uptake. Uptake was most efficient when citrate exceeded iron >100-fold, as was intracellular ROS formation and extracellular iron detectability using the LPI assay. Apotransferrin, when in excess, inhibited iron uptake, decreased intracellular ROS and decreased NTBI species detectable by LPI assay. However, at very high NTBI concentrations (≥10µM), when the iron content of ferric citrate (FC) exceeded the binding capacity of ApoTf, iron uptake was increased above that seen without transferrin present. Under these conditions ferric monocitrate species exist that are both LPI-detectable and enter myocardium. We propose that in TDT, transient generation of ApoTf under conditions of high residual erythropoiesis decreases MH by binding LPI-detectable species of NTBI. Qualitative differences in NTBI are therefore crucial to predict MH in TDT. Attempting to demonstrate relevant NTBI speciation differences we compared two methods: NTA-NTBI and a novel bead-NTBI. This approach, however, highlighted important methodological drawbacks rather than positive species identification; therefore, more work is needed in NTBI detection to elucidate the speciation further.
author Garbowski, M. W.
author_facet Garbowski, M. W.
author_sort Garbowski, M. W.
title Molecular and clinical factors affecting myocardial iron retention in transfusional haemosiderosis
title_short Molecular and clinical factors affecting myocardial iron retention in transfusional haemosiderosis
title_full Molecular and clinical factors affecting myocardial iron retention in transfusional haemosiderosis
title_fullStr Molecular and clinical factors affecting myocardial iron retention in transfusional haemosiderosis
title_full_unstemmed Molecular and clinical factors affecting myocardial iron retention in transfusional haemosiderosis
title_sort molecular and clinical factors affecting myocardial iron retention in transfusional haemosiderosis
publisher University College London (University of London)
publishDate 2017
url https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.763167
work_keys_str_mv AT garbowskimw molecularandclinicalfactorsaffectingmyocardialironretentionintransfusionalhaemosiderosis
_version_ 1718998242050441216